Search

everythinglearnresearchcommunity

for

Search:↓

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Environmental factors and exposure to toxins may contribute to male infertility by affecting sperm and hormone function.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

The document concludes that better training and education are needed for proper cancer screening and criticizes the GMC's inaction as harmful to clinical ethics in the UK.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Fat transfer can be effective for soft tissue trauma if the patient is chosen carefully and the procedure is done correctly.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Finasteride can slow hair loss and promote growth in postmenopausal women.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Higher BMI links to worse hair loss in Taiwanese men.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

PRP may help reduce musculoskeletal pain, but its effectiveness is still uncertain.

PRP therapy may improve skin and hair conditions, but more research with standard methods is needed.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Platelet-Rich Plasma (PRP) treatment may increase hair growth for genetic hair loss, but more research is needed to confirm this.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Mesotherapy for hair loss lacks evidence of effectiveness and safety and should not be used without further scientific support.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.